Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)

BACKGROUND: This multicenter, open-label, single-arm phase II study [Niigata Lung Cancer Treatment Group (NLCTG) 1302] was conducted to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy for previously treated patients with advanced non-small cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Satoshi, Miura, Satoru, Watanabe, Satoshi, Ohtsubo, Aya, Nozaki, Koichiro, Saida, Yu, Ichikawa, Kosuke, Kondo, Rie, Tanaka, Tomohiro, Koyama, Kenichi, Tanaka, Hiroshi, Okajima, Masaaki, Abe, Tetsuya, Ota, Takeshi, Ishida, Takashi, Makino, Masato, Iwashima, Akira, Sato, Kazuhiro, Matsumoto, Naoya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359941/
https://www.ncbi.nlm.nih.gov/pubmed/35958345
http://dx.doi.org/10.21037/tlcr-22-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359941/
https://www.ncbi.nlm.nih.gov/pubmed/35958345
http://dx.doi.org/10.21037/tlcr-22-89

Ejemplares similares